Table 2 Primary and secondary outcome measures at pre- and post-assessment.

From: Generalization of beneficial exposure effects to untreated stimuli from another fear category

Variable

Exposure group

Control group

P-value

M

(SD)

M

(SD)

Primary outcome measures

Spider BAT

BAT score pre

5.29

(1.81)

4.88

(2.05)

0.461

BAT score post

9.21

(2.04)

5.54

(2.01)

<0.001***

SUDS score pre

55.83

(18.81)

58.65

(20.23)

0.613

SUDS score post

Initial

20.00

(15.40)

51.73

(19.85)

<0.001***

Final

46.88

(24.66)

63.46

(22.19)

0.012*

Height BAT

BAT score pre

7.46

(2.34)

7.58

(2.28)

0.857

BAT score post

9.83

(2.62)

8.81

(2.15)

0.136

SUDS score pre

68.54

(17.85)

68.85

(16.14)

0.950

SUDS score post

Initial

48.88

(20.39)

53.00

(20.97)

0.489

Final

67.50

(22.94)

72.27

(15.02)

0.385

Secondary outcome measures

FSQ

Pre (α = 0.901)

65.91

(21.72)

70.85

(17.08)

0.379

Post (α = 0.968)

26.70

(16.49)

71.88

(19.25)

<0.001***

SBQ

Pre (α = 0.943)

25.27

(8.15)

27.31

(7.94)

0.386

Post (α = 0.978)

11.65

(7.45)

26.74

(8.27)

<0.001***

SPQ

Pre (α = 0.765)

19.71

(4.58)

20.58

(4.54)

0.522

Post (α = 0.837)

15.71

(5.22)

20.42

(4.86)

0.003**

AQ

Pre (α = 0.839)

58.64

(19.84)

67.41

(14.70)

0.103

Post (α = 0.898)

47.00

(17.10)

64.32

(21.38)

0.005**

  1. Internal consistency (Cronbach’s Alpha values) for each scale in our sample is provided in parentheses below the respective abbreviations for the pre- and post-assessment.
  2. BAT Behavioral Approach Test, SUDS Subjective Units of Distress Scale, FSQ Fear of Spiders Questionnaire, high fear ≥55, SBQ Spider Beliefs Questionnaire, high fear ≥26, SPQ Spider Phobia Questionnaire, clinically significant symptom severity ≥20, AQ Acrophobia Questionnaire, high fear ≥45.
  3. Significant between-group differences from independent T-tests, with ***P < 0.001, **P < 0.01, *P < 0.05.